nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxemia—Methotrexate—colon cancer	0.0753	0.0753	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Vincristine—colon cancer	0.0584	0.0584	CcSEcCtD
Cisatracurium Besylate—Azotaemia—Methotrexate—colon cancer	0.0283	0.0283	CcSEcCtD
Cisatracurium Besylate—Injury—Irinotecan—colon cancer	0.0239	0.0239	CcSEcCtD
Cisatracurium Besylate—Hypoxia—Methotrexate—colon cancer	0.0238	0.0238	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Irinotecan—colon cancer	0.0227	0.0227	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Vincristine—colon cancer	0.0215	0.0215	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Irinotecan—colon cancer	0.0209	0.0209	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Fluorouracil—colon cancer	0.02	0.02	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Vincristine—colon cancer	0.0199	0.0199	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Fluorouracil—colon cancer	0.0186	0.0186	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Irinotecan—colon cancer	0.0155	0.0155	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Vincristine—colon cancer	0.0154	0.0154	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Irinotecan—colon cancer	0.015	0.015	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Vincristine—colon cancer	0.0142	0.0142	CcSEcCtD
Cisatracurium Besylate—Flushing—Irinotecan—colon cancer	0.0141	0.0141	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Vincristine—colon cancer	0.0141	0.0141	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Capecitabine—colon cancer	0.014	0.014	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Irinotecan—colon cancer	0.0138	0.0138	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Irinotecan—colon cancer	0.0138	0.0138	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Irinotecan—colon cancer	0.0137	0.0137	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Capecitabine—colon cancer	0.013	0.013	CcSEcCtD
Cisatracurium Besylate—Erythema—Fluorouracil—colon cancer	0.0127	0.0127	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Capecitabine—colon cancer	0.0125	0.0125	CcSEcCtD
Cisatracurium Besylate—Convulsion—Vincristine—colon cancer	0.0118	0.0118	CcSEcCtD
Cisatracurium Besylate—Hypertension—Vincristine—colon cancer	0.0117	0.0117	CcSEcCtD
Cisatracurium Besylate—Hypertension—Irinotecan—colon cancer	0.0114	0.0114	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Methotrexate—colon cancer	0.0113	0.0113	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Vincristine—colon cancer	0.0111	0.0111	CcSEcCtD
Cisatracurium Besylate—Convulsion—Fluorouracil—colon cancer	0.011	0.011	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Vincristine—colon cancer	0.0109	0.0109	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Irinotecan—colon cancer	0.0108	0.0108	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Irinotecan—colon cancer	0.0106	0.0106	CcSEcCtD
Cisatracurium Besylate—Hypotension—Vincristine—colon cancer	0.0104	0.0104	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Capecitabine—colon cancer	0.0104	0.0104	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Fluorouracil—colon cancer	0.0104	0.0104	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Fluorouracil—colon cancer	0.0102	0.0102	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Fluorouracil—colon cancer	0.0101	0.0101	CcSEcCtD
Cisatracurium Besylate—Hypotension—Irinotecan—colon cancer	0.0101	0.0101	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Capecitabine—colon cancer	0.01	0.01	CcSEcCtD
Cisatracurium Besylate—Hypotension—Fluorouracil—colon cancer	0.00968	0.00968	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Irinotecan—colon cancer	0.00964	0.00964	CcSEcCtD
Cisatracurium Besylate—Flushing—Capecitabine—colon cancer	0.00946	0.00946	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Capecitabine—colon cancer	0.00924	0.00924	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Fluorouracil—colon cancer	0.00924	0.00924	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Capecitabine—colon cancer	0.0092	0.0092	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Capecitabine—colon cancer	0.00918	0.00918	CcSEcCtD
Cisatracurium Besylate—Erythema—Capecitabine—colon cancer	0.00887	0.00887	CcSEcCtD
Cisatracurium Besylate—Urticaria—Fluorouracil—colon cancer	0.00823	0.00823	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Vincristine—colon cancer	0.00818	0.00818	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Irinotecan—colon cancer	0.00797	0.00797	CcSEcCtD
Cisatracurium Besylate—Hypertension—Capecitabine—colon cancer	0.00766	0.00766	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Fluorouracil—colon cancer	0.00763	0.00763	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.0075	0.0075	CcSEcCtD
Cisatracurium Besylate—Pruritus—Fluorouracil—colon cancer	0.00733	0.00733	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Capecitabine—colon cancer	0.0071	0.0071	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Capecitabine—colon cancer	0.00707	0.00707	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Capecitabine—colon cancer	0.00703	0.00703	CcSEcCtD
Cisatracurium Besylate—Rash—Vincristine—colon cancer	0.007	0.007	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Vincristine—colon cancer	0.007	0.007	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Methotrexate—colon cancer	0.00688	0.00688	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Methotrexate—colon cancer	0.00685	0.00685	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Methotrexate—colon cancer	0.00684	0.00684	CcSEcCtD
Cisatracurium Besylate—Rash—Irinotecan—colon cancer	0.00682	0.00682	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Irinotecan—colon cancer	0.00681	0.00681	CcSEcCtD
Cisatracurium Besylate—Hypotension—Capecitabine—colon cancer	0.00676	0.00676	CcSEcCtD
Cisatracurium Besylate—Erythema—Methotrexate—colon cancer	0.0066	0.0066	CcSEcCtD
Cisatracurium Besylate—Rash—Fluorouracil—colon cancer	0.00653	0.00653	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Fluorouracil—colon cancer	0.00653	0.00653	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Capecitabine—colon cancer	0.00645	0.00645	CcSEcCtD
Cisatracurium Besylate—Urticaria—Capecitabine—colon cancer	0.00575	0.00575	CcSEcCtD
Cisatracurium Besylate—Convulsion—Methotrexate—colon cancer	0.00572	0.00572	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.00558	0.00558	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Methotrexate—colon cancer	0.00539	0.00539	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Capecitabine—colon cancer	0.00533	0.00533	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Methotrexate—colon cancer	0.00528	0.00528	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Methotrexate—colon cancer	0.00523	0.00523	CcSEcCtD
Cisatracurium Besylate—Pruritus—Capecitabine—colon cancer	0.00512	0.00512	CcSEcCtD
Cisatracurium Besylate—Hypotension—Methotrexate—colon cancer	0.00504	0.00504	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Methotrexate—colon cancer	0.0048	0.0048	CcSEcCtD
Cisatracurium Besylate—Rash—Capecitabine—colon cancer	0.00456	0.00456	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Capecitabine—colon cancer	0.00456	0.00456	CcSEcCtD
Cisatracurium Besylate—Urticaria—Methotrexate—colon cancer	0.00428	0.00428	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Methotrexate—colon cancer	0.00397	0.00397	CcSEcCtD
Cisatracurium Besylate—Pruritus—Methotrexate—colon cancer	0.00381	0.00381	CcSEcCtD
Cisatracurium Besylate—Rash—Methotrexate—colon cancer	0.0034	0.0034	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Methotrexate—colon cancer	0.00339	0.00339	CcSEcCtD
